NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Show me German enrollment and I'll show you the reason for the hold.

Doc logic,

IMO enrollment was completed in the U.S. (216 patients in the U.S.and 132 outside the U.S.= 348 newly diagnosted GBM patients) at the time of the partial clinical hold on screening by the FDA.

Western Neurosurgical Society 62nd Annual Meeting
Sunday, September 11, 2016
Brain Tumor Immunotherapy: Against All Odds.

Linda Liau:
Recruitment completed in de U.S. (n=331)

I still wonder why Northwest Biotherapeutics waited 3 months to confirm the number of 331 patients enrolled in the trial.

Presentation Linda Liau: September 11, 2016
Press Release Northwest Biotherapeutics : December 8, 2016 (https://nwbio.com/nw-bio-provides-update-about-phase-3-trial-of-dcvax-l-for-newly-diagnosed-glioblastoma-multiforme-brain-cancer/)

link:
Western Neurosurgical Society 62nd Annual Meeting
Sunday, September 11, 2016.
P.22
Program
http://www.westnsurg.org/pdfs/2016%20Annual%20Meeting%20Program.pdf

presentation Linda Liau:
http://www.westnsurg.org/pdfs/Presidential%20address%202016-Linda%20%20Liau.pdf

2016 MEETING SUMMARY.

2016 MEETING SUMMARY

The 62nd Annual Meeting of the Western Neurosurgical Society was held at the Park Hyatt Aviara Resort in Carlsbad, CA, September 9-12, 2016. WNS President Linda Liau presided.

The meeting was attended by 94 members and professional guests and supported by 27 exhibitors, including Medtronic Spine that for the second time provided support at the Platinum Level; Arbor Pharmaceutical that provided support at the gold level and DePuy Synthes and Haag-Streit that provided support at the silver level. It is the exhibitors who make the meeting possible at the level of registration fee we charge.

http://www.westnsurg.org/WNS-2016FallNewsletter.html

2016 Annual Meeting Program on Website

For those of you who were unable to attend the annual meeting this year, the program booklet is available on our Website (westnsurg.org) as a pdf file you can download.